The protein S100B shows a strong affinity for the **V-domain of the Receptor for Advanced Glycation End products (RAGE)**. It can be used as both an **adjunct marker** to assess ongoing neuroinflammation and cellular damage and as a **prognostic marker** to predict disease severity and clinical outcomes in neurological disorders.